NM_001009944.3:c.8644T>A

Variant summary

Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_001009944.3(PKD1):​c.8644T>A​(p.Trp2882Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00877 in 1,599,366 control chromosomes in the GnomAD database, including 1,050 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.047 ( 553 hom., cov: 31)
Exomes 𝑓: 0.0048 ( 497 hom. )

Consequence

PKD1
NM_001009944.3 missense

Scores

18

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:7

Conservation

PhyloP100: 0.124
Variant links:
Genes affected
PKD1 (HGNC:9008): (polycystin 1, transient receptor potential channel interacting) This gene encodes a member of the polycystin protein family. The encoded glycoprotein contains a large N-terminal extracellular region, multiple transmembrane domains and a cytoplasmic C-tail. It is an integral membrane protein that functions as a regulator of calcium permeable cation channels and intracellular calcium homoeostasis. It is also involved in cell-cell/matrix interactions and may modulate G-protein-coupled signal-transduction pathways. It plays a role in renal tubular development, and mutations in this gene cause autosomal dominant polycystic kidney disease type 1 (ADPKD1). ADPKD1 is characterized by the growth of fluid-filled cysts that replace normal renal tissue and result in end-stage renal failure. Splice variants encoding different isoforms have been noted for this gene. Also, six pseudogenes, closely linked in a known duplicated region on chromosome 16p, have been described. [provided by RefSeq, Oct 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0021344721).
BP6
Variant 16-2103413-A-T is Benign according to our data. Variant chr16-2103413-A-T is described in ClinVar as [Likely_benign]. Clinvar id is 257025.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2103413-A-T is described in Lovd as [Likely_benign].
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.158 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
PKD1NM_001009944.3 linkc.8644T>A p.Trp2882Arg missense_variant Exon 23 of 46 ENST00000262304.9 NP_001009944.3

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
PKD1ENST00000262304.9 linkc.8644T>A p.Trp2882Arg missense_variant Exon 23 of 46 1 NM_001009944.3 ENSP00000262304.4 P98161-1

Frequencies

GnomAD3 genomes
AF:
0.0469
AC:
7130
AN:
152152
Hom.:
553
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.161
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0219
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00124
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.0127
Gnomad NFE
AF:
0.000441
Gnomad OTH
AF:
0.0363
GnomAD3 exomes
AF:
0.0118
AC:
2759
AN:
233310
Hom.:
212
AF XY:
0.00872
AC XY:
1127
AN XY:
129210
show subpopulations
Gnomad AFR exome
AF:
0.168
Gnomad AMR exome
AF:
0.00896
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.000394
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000390
Gnomad OTH exome
AF:
0.00409
GnomAD4 exome
AF:
0.00476
AC:
6894
AN:
1447096
Hom.:
497
Cov.:
34
AF XY:
0.00396
AC XY:
2853
AN XY:
720446
show subpopulations
Gnomad4 AFR exome
AF:
0.163
Gnomad4 AMR exome
AF:
0.0103
Gnomad4 ASJ exome
AF:
0.0000383
Gnomad4 EAS exome
AF:
0.0000252
Gnomad4 SAS exome
AF:
0.000418
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.000247
Gnomad4 OTH exome
AF:
0.0110
GnomAD4 genome
AF:
0.0469
AC:
7139
AN:
152270
Hom.:
553
Cov.:
31
AF XY:
0.0450
AC XY:
3350
AN XY:
74472
show subpopulations
Gnomad4 AFR
AF:
0.161
Gnomad4 AMR
AF:
0.0218
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00104
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.000441
Gnomad4 OTH
AF:
0.0360
Alfa
AF:
0.0190
Hom.:
43
Bravo
AF:
0.0536
ESP6500AA
AF:
0.130
AC:
515
ESP6500EA
AF:
0.000770
AC:
6
ExAC
AF:
0.0137
AC:
1602
Asia WGS
AF:
0.00895
AC:
31
AN:
3476
EpiCase
AF:
0.000164
EpiControl
AF:
0.000474

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:7
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
-
Breakthrough Genomics, Breakthrough Genomics
Significance: Likely benign
Review Status: criteria provided, single submitter
Collection Method: not provided

- -

Oct 11, 2019
GeneDx
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

This variant is associated with the following publications: (PMID: 17574468, 17582161, 22008521) -

Oct 23, 2017
Athena Diagnostics
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Polycystic kidney disease, adult type Benign:1
Dec 17, 2019
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Polycystic kidney disease Benign:1
-
Department of Pathology and Laboratory Medicine, Sinai Health System
Significance: Benign
Review Status: no assertion criteria provided
Collection Method: clinical testing

The PKD1 p.Trp2882Arg variant is identified in the literature in 3 of 716 proband chromosomes (frequency: 0.004) as a polymorphism from individuals or families with ADPKD, but it was not identified in 442 control chromosomes from healthy individuals (Bataille 2011, Rossetti 2007, Garcia-Gonzalez 2007). In addition the PKD1 p.Glu2966Asp variant was reported as co-occurring with 2 pathogenic PKD1 variants (1470A>G, Y420C and 4262C>T, R1351W) in a proband (Garcia-Gonzalez_2007). The variant was also identified in dbSNP (ID: rs13333553) as “With Benign allele”, Clinvitae (as benign), ClinVar (as benign, by Prevention Genetics), ADPKD Mutation Database (as likely neutral). This variant was identified in the 1000 Genomes Project in 254 of 5008 chromosomes (frequency: 0.050), the NHLBI GO Exome Sequencing Project in 6 of 7794 European American alleles (freq: 0.0007) and in 515 of 3964 African American alleles (freq: 0.13), the genome Aggregation Database (beta, October 19th 2016) in 3124 (239 homozygous) of 236960 chromosomes (freq. 0.013), the Exome Aggregation Consortium database (August 8th 2016) in 1510 (122 homozygous) of 112386 chromosomes (freq. 0.013) in the following populations: African in 1403 of 8206 chromosomes (freq. 0.171), Latino in 80 of 11338 chromosomes (freq. 0.007), other in 5 of 832 chromosomes (freq. 0.006), South Asian in 6 of 16338 chromosomes (freq. 0.0003), and European in 16 of 60860 chromosomes (freq. 0.0002), but was not seen in East Asian and Finnish populations. The variant was identified by our laboratory in 2 individuals with ADPKD, co-occurring with a pathogenic PKD1 variant (c.3489delC, p.Phe1163Leufsx8 and c.2494dupC, p.Arg832ProfsX40), increasing the likelihood that the p.Trp2882Arg variant does not have clinical significance. The p.Trp2882Arg variant was not identified in the PKD1-LOVD, PKD1-LOVD 3.0, COGR and HAPMAP databases. The p.Trp2882 residue is not conserved in mammals and other organisms and four out of five computational analyses (PolyPhen-2, SIFT, AlignGVGD, BLOSUM, MutationTaster) do not suggest a high likelihood of impact to the protein; however, this information is not predictive enough to rule out pathogenicity. The variant occurs outside of the splicing consensus sequence and 1 of 5 in silico or computational prediction software programs (SpliceSiteFinder, MaxEntScan, NNSPLICE, GeneSplicer, HumanSpliceFinder) predict a greater than 10% difference in splicing; this is not very predictive of pathogenicity. In summary, based on the above information, this variant meets our laboratory criteria to be classified as benign. -

Autosomal dominant polycystic kidney disease Benign:1
Jan 01, 2019
Molecular Genetics of Inherited Kidney Disorders Laboratory, Garvan Institute of Medical Research
Significance: Likely benign
Review Status: criteria provided, single submitter
Collection Method: research

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.082
BayesDel_addAF
Benign
-0.78
T
BayesDel_noAF
Benign
-0.75
CADD
Benign
7.1
DANN
Benign
0.46
DEOGEN2
Benign
0.13
T;.
Eigen
Benign
-1.0
Eigen_PC
Benign
-0.99
FATHMM_MKL
Benign
0.10
N
LIST_S2
Benign
0.29
T;T
MetaRNN
Benign
0.0021
T;T
MetaSVM
Benign
-1.0
T
MutationAssessor
Benign
0.0
N;N
PrimateAI
Benign
0.26
T
PROVEAN
Benign
-0.83
N;N
REVEL
Benign
0.076
Sift
Benign
0.37
T;T
Sift4G
Benign
0.46
T;T
Polyphen
0.054
B;B
Vest4
0.10
MutPred
0.46
Gain of disorder (P = 0.0026);Gain of disorder (P = 0.0026);
ClinPred
0.00031
T
GERP RS
2.6
Varity_R
0.034
gMVP
0.55

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs13333553; hg19: chr16-2153414; COSMIC: COSV51920157; COSMIC: COSV51920157; API